Bristol-Myers Squibb-CVRPreferred / convertible
13F holders, Q1 2024 (March 31)1holders
$0.00avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Bristol-Myers Squibb-CVR in their 13F filings. The largest holder was Beddow Capital Management Inc. ($0).
- Company
- Bristol-Myers Squibb-CVR
- CUSIP
- 110122157
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Beddow Capital Management Inc. | — | No change | 560,789 | $0 |
"% of holder's portfolio" is BRISTOL-MYERS SQUIBB-CVR's weight in each manager's 13F, not the share of Bristol-Myers Squibb-CVR the manager owns.